Wells Fargo’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-154
| Closed | -$150 | – | 7753 |
|
|
2023
Q3 | $150 | Buy |
154
+11
| +8% | +$8 | ﹤0.01% | 6653 |
|
|
2023
Q2 | $100 | Buy |
143
+23
| +19% | +$14 | ﹤0.01% | 6868 |
|
|
2023
Q1 | $79 | Buy |
120
+2
| +2% | +$3 | ﹤0.01% | 6989 |
|
|
2022
Q4 | $177 | Buy |
118
+1
| +0.9% | +$2 | ﹤0.01% | 6652 |
|
|
2022
Q3 | $0 | Hold |
117
| – | – | ﹤0.01% | 7668 |
|
|
2022
Q2 | $1K | Buy |
117
+47
| +67% | +$425 | ﹤0.01% | 6670 |
|
|
2022
Q1 | $1K | Hold |
70
| – | – | ﹤0.01% | 6898 |
|
|
2021
Q4 | $1K | Buy |
70
+3
| +4% | +$54 | ﹤0.01% | 7113 |
|
|
2021
Q3 | $2K | Hold |
67
| – | – | ﹤0.01% | 6617 |
|
|
2021
Q2 | $2K | Buy |
67
+4
| +6% | +$164 | ﹤0.01% | 6580 |
|
|
2021
Q1 | $3K | Buy |
63
+55
| +688% | +$3.02K | ﹤0.01% | 6604 |
|
|
2020
Q4 | $0 | Buy |
8
+7
| +700% | +$220 | ﹤0.01% | 7211 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 7101 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 7004 |
|
|
2020
Q1 | $0 | Buy |
+1
| New | +$78 | ﹤0.01% | 7007 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6588 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6525 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6515 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6571 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6501 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6397 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6397 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6504 |
|
|
2015
Q4 | – | Sell |
-1
| Closed | -$1.3K | – | 6125 |
|
|
2015
Q3 | $1K | Sell |
1
-6
| -86% | -$11.6K | ﹤0.01% | 6092 |
|
|
2015
Q2 | $15K | Buy |
7
+1
| +17% | +$3.14K | ﹤0.01% | 5695 |
|
|
2015
Q1 | $19K | Hold |
6
| – | – | ﹤0.01% | 5406 |
|
|
2014
Q4 | $21K | Sell |
6
-1
| -14% | -$3.54K | ﹤0.01% | 5350 |
|
|
2014
Q3 | $25K | Buy |
7
+1
| +17% | +$3.89K | ﹤0.01% | 5211 |
|
|
2014
Q2 | $25K | Sell |
6
-1
| -14% | -$3.76K | ﹤0.01% | 5283 |
|
|
2014
Q1 | $30K | Hold |
7
| – | – | ﹤0.01% | 5097 |
|
|
2013
Q4 | $27K | Sell |
7
-24
| -77% | -$90.9K | ﹤0.01% | 4931 |
|
|
2013
Q3 | $120K | Hold |
31
| – | – | ﹤0.01% | 4412 |
|
|
2013
Q2 | $303K | Buy |
+31
| New | +$343K | ﹤0.01% | 3922 |
|
Other funds holding FRTX
Wells Fargo's FRTX Position: Q4 2023 in Review
Wells Fargo sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2023, closing a stake of 154 shares — an estimated $150 sold.
Wells Fargo first reported a position in FRTX in Q2 2013 and held it in 25 quarters. The position peaked at $303K in Q2 2013. 1 fund tracked by Wall St. Rank holds FRTX as of Q4 2023.
- Wells Fargo reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Wells Fargo sold 154 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $150.
- Wells Fargo first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 25 quarters.
- Wells Fargo's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $303K in Q2 2013.
- 1 fund tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2023.
Based on Wells Fargo's 13F filing for Q4 2023, filed 9 Feb 2024.